Atsushi Usami
Direktor/Vorstandsmitglied bei GORYO Chemical, Inc.
Profil
Atsushi Usami is currently a Director at GORYO Chemical, Inc. and BUGWORKS Research, Inc. He previously worked as a Director at Cyfuse Biomedical KK and Repertoire Genesis, Inc. He also worked as a Strategy Consultant at Mitsubishi Research Institute, Inc. and as an Auditor at Molcure, Inc. Dr. Usami holds a doctorate degree from the University of Tokyo.
Aktive Positionen von Atsushi Usami
| Unternehmen | Position | Beginn |
|---|---|---|
GORYO Chemical, Inc.
 GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Direktor/Vorstandsmitglied | - |
BUGWORKS Research, Inc.
 BUGWORKS Research, Inc. Pharmaceuticals: MajorHealth Technology BUGWORKS Research, Inc. operates as a drug discovery company that discovers novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded by Santanu Datta, Anand Anandkumar and V. Balasubramanian in 2014 and is headquartered in Saratoga, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Atsushi Usami
| Unternehmen | Position | Ende |
|---|---|---|
| REPERTOIRE GENESIS INC. | Direktor/Vorstandsmitglied | - |
Molcure, Inc.
 Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | - |
| CYFUSE BIOMEDICAL K.K. | Direktor/Vorstandsmitglied | - |
| MITSUBISHI RESEARCH INSTITUTE, INC. | Corporate Officer/Principal | - |
Ausbildung von Atsushi Usami
| University of Tokyo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MITSUBISHI RESEARCH INSTITUTE, INC. | Commercial Services |
| CYFUSE BIOMEDICAL K.K. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Health Technology |
GORYO Chemical, Inc.
GORYO Chemical, Inc. Chemicals: Major DiversifiedProcess Industries GORYO Chemical, Inc. develops and sells fluorescent probes. It offers Fluorescence imaging, Cancer Targets, in vitro cellular assay, in vivo imaging, cell, Super-Resolution Microscopy, Optical Microscopy, Small Animal Molecular Imaging, Near Infrared Fluorescence, High Content Screening, Molecular Biology and Molecular Diagnostics. The company was founded on July 16, 2010 by Ken-ichi Maruyama and is headquartered in Sapporo, Japan. | Process Industries |
BUGWORKS Research, Inc.
BUGWORKS Research, Inc. Pharmaceuticals: MajorHealth Technology BUGWORKS Research, Inc. operates as a drug discovery company that discovers novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded by Santanu Datta, Anand Anandkumar and V. Balasubramanian in 2014 and is headquartered in Saratoga, CA. | Health Technology |
Repertoire Genesis, Inc.
 Repertoire Genesis, Inc. Packaged SoftwareTechnology Services Repertoire Genesis, Inc. develops a TCR/BCR repertoire analytical software. The company was founded in 2014 and is headquartered in Ibaraki, Japan | Technology Services |
